ABCG2 p.Lys453Asp
Predicted by SNAP2: | A: N (66%), C: D (59%), D: D (59%), E: N (53%), F: D (71%), G: N (53%), H: N (72%), I: N (57%), L: D (53%), M: N (57%), N: N (66%), P: D (59%), Q: N (72%), R: N (66%), S: N (61%), T: N (66%), V: N (66%), W: D (75%), Y: D (66%), |
Predicted by PROVEAN: | A: D, C: D, D: D, E: N, F: D, G: D, H: D, I: D, L: D, M: D, N: D, P: D, Q: N, R: N, S: D, T: D, V: D, W: D, Y: D, |
[switch to compact view]
Comments [show]
None has been submitted yet.
[hide] Role of basic residues within or near the predicte... J Pharmacol Exp Ther. 2010 Jun;333(3):670-81. Epub 2010 Mar 4. Cai X, Bikadi Z, Ni Z, Lee EW, Wang H, Rosenberg MF, Mao Q
Role of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer resistance protein in drug transport.
J Pharmacol Exp Ther. 2010 Jun;333(3):670-81. Epub 2010 Mar 4., [PMID:20203106]
Abstract [show]
The human breast cancer resistance protein (BCRP/ABCG2) mediates efflux of drugs and xenobiotics out of cells. In this study, we investigated the role of five basic residues within or near transmembrane (TM) 2 of BCRP in transport activity. Lys(452), Lys(453), His(457), Arg(465), and Lys(473) were replaced with Ala or Asp. K452A, K453D, H457A, R465A, and K473A were stably expressed in human embryonic kidney (HEK) cells, and their plasma membrane expression and transport activities were examined. All of the mutants were expressed predominantly on the plasma membrane of HEK cells. After normalization to BCRP levels, the activities of K452A and H457A in effluxing mitoxantrone, boron-dipyrromethene-prazosin, and Hoechst33342 were increased approximately 2- to 6-fold compared with those of wild-type BCRP, whereas the activities of K453D and R465A were decreased by 40 to 60%. Likewise, K452A and H457A conferred increased resistance to mitoxantrone and 7-ethyl-10-hydroxy-camptothecin (SN-38), and K453D and R465A exhibited lower resistance. The transport activities and drug-resistance profiles of K473A were not changed. These mutations also differentially affected BCRP ATPase activities with a 2- to 4-fold increase in V(max)/K(m) for K452A and H457A and a 40 to 70% decrease for K453D and R465A. These mutations may induce conformational changes as manifested by the altered binding of the 5D3 antibody to BCRP in the presence of prazosin and altered trypsin digestion. Molecular modeling and docking calculations indicated that His(457) and Arg(465) might be directly involved in substrate binding. In conclusion, we have identified several basic residues within or near TM2 that may be important for interaction of substrates with BCRP.
Comments [show]
None has been submitted yet.
No. Sentence Comment
3 K452A, K453D, H457A, R465A, and K473A were stably expressed in human embryonic kidney (HEK) cells, and their plasma membrane expression and transport activities were examined.
X
ABCG2 p.Lys453Asp 20203106:3:7
status: VERIFIED5 After normalization to BCRP levels, the activities of K452A and H457A in effluxing mitoxantrone, boron-dipyrromethene-prazosin, and Hoechst33342 were increased approximately 2to 6-fold compared with those of wild-type BCRP, whereas the activities of K453D and R465A were decreased by 40 to 60%.
X
ABCG2 p.Lys453Asp 20203106:5:250
status: VERIFIED6 Likewise, K452A and H457A conferred increased resistance to mitoxantrone and 7-ethyl-10-hydroxy-camptothecin (SN-38), and K453D and R465A exhibited lower resistance.
X
ABCG2 p.Lys453Asp 20203106:6:122
status: VERIFIED8 These mutations also differentially affected BCRP ATPase activities with a 2to 4-fold increase in Vmax/Km for K452A and H457A and a 40 to 70% decrease for K453D and R465A.
X
ABCG2 p.Lys453Asp 20203106:8:155
status: VERIFIED76 The polymerase chain reaction-based mutagenesis was performed according to the manufacturer`s instructions with the following forward primers: K452A (5Ј-gaa ctc ttt gtg gta gag GCg aag ctc ttc ata cat gaa-3Ј), K453D (5Ј-ctc ttt gtg gta gag aag GaC ctc ttc ata cat gaa tac-3Ј), H457A (5Ј-gag aag aag ctc ttc ata GCt gaa tac atc agc gga tac-3Ј), R465A (5Ј-tac atc agc gga tac tac GCa gtg tca tct tat ttc ctt-3Ј), and K473A (5Ј-tca tct tat ttc ctt gga GCa ctg tta tct gat tta tta-3Ј).
X
ABCG2 p.Lys453Asp 20203106:76:222
status: VERIFIED178 Because substitution of Lys453 with Asp showed substantially higher levels of expression than substitution with Ala in all the clones obtained in this study, we examined substitution of Lys453 with Asp that may affect BCRP activity if the positive charge of Lys453 is functionally essential.
X
ABCG2 p.Lys453Asp 20203106:178:24
status: VERIFIEDX
ABCG2 p.Lys453Asp 20203106:178:186
status: VERIFIED183 The expression levels of the mutants K452A, K453D, H457A, R465A, and K473A, determined by immunoblotting of whole-cell lysates using beta-actin as an internal standard, were approximately 0.74-, 2.56-, 0.24-, 3.87-, and 1.56-fold that of wild-type BCRP (Fig. 2, A and B).
X
ABCG2 p.Lys453Asp 20203106:183:44
status: VERIFIED191 A, a representative immunoblot of whole-cell lysates for wild-type BCRP and the mutants K452A, K453D, H457A, R465A, and K473A.
X
ABCG2 p.Lys453Asp 20203106:191:95
status: VERIFIED207 After normalization to the BCRP levels of whole-cell lysates, statistically significant differences in efflux activities for all three substrates were noticed for K452A, K453D, H457A, and R465A compared with wild-type protein.
X
ABCG2 p.Lys453Asp 20203106:207:170
status: VERIFIED209 Thus, the efflux activities of K452A and H457A were significantly increased 2to 6-fold, whereas the activities of K453D and R465A were decreased by 40 to 60%, depending on substrate (Table 1).
X
ABCG2 p.Lys453Asp 20203106:209:114
status: VERIFIED220 After normalization to the BCRP levels, the IC50 values of cells expressing K452A, K453D, H457A, and R465A for MX and SN-38 were significantly different from those of cells expressing wild-type BCRP, whereas the IC50 values of cells expressing K473A and wild-type protein were comparable.
X
ABCG2 p.Lys453Asp 20203106:220:83
status: VERIFIED221 Thus, the relative levels of resistance of K452A and H457A to MX were increased approximately 2to 3-fold compared with wild-type protein, whereas those of K453D and R465A to MX were decreased by 30 to 70%.
X
ABCG2 p.Lys453Asp 20203106:221:155
status: VERIFIED222 Likewise, the relative levels of resistance of H457A to SN-38 were increased approximately 3-fold, whereas those of K453D and R465A to SN-38 were decreased by 50 to 60%.
X
ABCG2 p.Lys453Asp 20203106:222:116
status: VERIFIED232 The Km values of K453D, R465A, and K473A were comparable with that of wild-type protein; however, the Km values of K452A and H457A were decreased by approximately 50 and 70%, respectively, suggesting that these two mutations, particularly the one at position 457, increased the binding affinity of ATP to BCRP.
X
ABCG2 p.Lys453Asp 20203106:232:17
status: VERIFIED234 After normalization to the BCRP levels, the Vmax values of K453D and R465A were approximately 60% lower than that of wild-type BCRP, whereas the Vmax values of other mutants did not change.
X
ABCG2 p.Lys453Asp 20203106:234:59
status: VERIFIED235 As a result, the Vmax/Km values of K452A and H457A were increased approximately 210 µm 10 µm 10 µm Wild-type BCRP K452A K453D 10 µm 10 µm10 µm 10 µm H457A R465A K473A Fig. 3.
X
ABCG2 p.Lys453Asp 20203106:235:135
status: VERIFIED241 Selected areas of HEK cells expressing wild-type BCRP and the mutants K452A, K453D, H457A, R465A, and K473A are shown.
X
ABCG2 p.Lys453Asp 20203106:241:77
status: VERIFIED244 In contrast, the Vmax/Km values of K453D and R465A were decreased by approximately 40 to 70%.
X
ABCG2 p.Lys453Asp 20203106:244:35
status: VERIFIED263 Mitoxantrone BODIPY-Prazosin Hoechst33342 ⌬F ⌬FЈ Ratio ⌬F ⌬FЈ Ratio ⌬F ⌬FЈ Ratio pcDNA vector 0 0 0 0 0 0 Wild-type BCRP 11.1 Ϯ 1.5 11.1 Ϯ 1.5 1.0 49.9 Ϯ 13.1 49.9 Ϯ 13.1 1.0 976.5 Ϯ 115.5 976.5 Ϯ 115.5 1.0 K452A 22.0 Ϯ 5.9 29.7 Ϯ 7.9* 2.7 76.6 Ϯ 22.5 103.5 Ϯ 30.4* 2.1 1138.3 Ϯ 134.7 1538.3 Ϯ 182.1* 1.6 K453D 19.1 Ϯ 5.9 7.5 Ϯ 3.3* 0.7 57.7 Ϯ 15.6 22.6 Ϯ 6.1* 0.4 1116.9 Ϯ 132.2 436.3 Ϯ 51.6* 0.4 H457A 4.5 Ϯ 2.1 18.7 Ϯ 8.7* 1.7 40.1 Ϯ 9.7 167.0 Ϯ 40.2* 3.3 1259.5 Ϯ 343.2 5247.9 Ϯ 1429.9* 5.4 R465A 26.1 Ϯ 3.0 6.8 Ϯ 0.8* 0.6 96.5 Ϯ 16.0 24.9 Ϯ 4.1* 0.5 2217.8 Ϯ 255.2 573.1 Ϯ 65.9* 0.6 K473A 22.2 Ϯ 5.0 14.3 Ϯ 3.2 1.3 83.2 Ϯ 17.6 53.3 Ϯ 11.3 1.1 1411.5 Ϯ 166.8 887.7 Ϯ 104.9 0.9 no effect on phycoerythrin fluorescence.
X
ABCG2 p.Lys453Asp 20203106:263:437
status: VERIFIED264 However, the addition of prazosin differentially increased the binding of 5D3 to wild-type BCRP, K452A, K453D, H457A, and R465A in a concentration-dependent manner (Fig. 6), suggesting that the binding equilibrium between prazosin and BCRP could be monitored by measuring the binding of 5D3 to the transporter.
X
ABCG2 p.Lys453Asp 20203106:264:104
status: VERIFIED265 Thus, the apparent dissociation constants of the prazosin complex with wild-type or mutant BCRP were estimated to be 5.3 Ϯ 1.1, 14.7 Ϯ 2.3, 3.1 Ϯ 0.4, 20.1 Ϯ 4.0, and 6.7 Ϯ 1.8 M for wild-type BCRP, K452A, K453D, H457A, and R465A, respectively.
X
ABCG2 p.Lys453Asp 20203106:265:244
status: VERIFIED289 Vanadate-sensitive ATPase activities of wild-type and mutant BCRP were measured with plasma membrane preparations over an ATP concentration range of 0 to 5 mM as described. Shown are means Ϯ S.D. of three independent experiments for wild-type BCRP (f), K452A (), K453D (F), H457A (‚), R465A (ࡗ), and K473A (छ).
X
ABCG2 p.Lys453Asp 20203106:289:275
status: VERIFIED297 MX SN-38 Dox Rho123 IC50 Relative Resistance (Ratio) IC50 Relative Resistance (Ratio) IC50 Relative Resistance IC50 Relative Resistance nM nM nM M pcDNA vector 24.0 Ϯ 3.5 2.4 Ϯ 0.3 24.0 Ϯ 8.7 7.26 Ϯ 1.15 Wild-type BCRP 145.1 Ϯ 52.8 6.0 (1.0) 125.3 Ϯ 6.1 52.2 (1.0) 31.5 Ϯ 12.6 1.3 10.97 Ϯ 1.84 1.5 K452A 354.8 Ϯ 68.6 14.8 (3.3)* 103.0 Ϯ 12.5 42.9 (1.1)* 24.2 Ϯ 4.4 1.0 9.27 Ϯ 1.75 1.3 K453D 244.0 Ϯ 99.9 10.2 (0.7)* 136.2 Ϯ 9.9 56.8 (0.4)* 34.0 Ϯ 6.7 1.4 8.22 Ϯ 0.97 1.1 H457A 71.9 Ϯ 12.8 3.0 (2.1)* 90.6 Ϯ 4.6 37.8 (3.0)* 21.8 Ϯ 16.6 0.9 7.61 Ϯ 1.29 1.0 R465A 169.1 Ϯ 49.0 7.0 (0.3)* 224.2 Ϯ 39.7 93.4 (0.5)* 37.9 Ϯ 17.5 1.6 14.65 Ϯ 1.26 2.0 K473A 243.1 Ϯ 114.0 10.1 (1.1) 188.0 Ϯ 19.2 78.3 (0.9) 36.0 Ϯ 10.1 1.5 15.11 Ϯ 1.43 2.1 not Lys452 , Lys453 , and Lys473 , seem to directly participate in the binding of all four substrates.
X
ABCG2 p.Lys453Asp 20203106:297:465
status: VERIFIED317 Wild-type BCRP K452A K453D H457A R465A K473A Vmax (nmol Pi/min/mg protein) 18.4 Ϯ 1.8 16.4 Ϯ 1.9 15.1 Ϯ 1.4 3.94 Ϯ 0.07 15.8 Ϯ 2.6 17.1 Ϯ 1.3 Vmax normalized to BCRP level (nmol Pi/min/mg protein) 18.4 Ϯ 1.8 18.4 Ϯ 2.1 7.4 Ϯ 0.7 19.6 Ϯ 0.3 6.7 Ϯ 1.1 17.6 Ϯ 1.3 Km for ATP (mM) 0.69 Ϯ 0.21 0.32 Ϯ 0.15 0.85 Ϯ 0.12 0.17 Ϯ 0.07 0.46 Ϯ 0.11 0.52 Ϯ 0.13 Vmax/Km (nmol Pi/min/mg protein/mM) 26.7 57.5 8.7 115.3 14.6 33.8 0 25 50 75 100 -0.25 0.00 0.25 0.50 0.75 1.00 1.25 Prazosin (µM) ∆F/F0 Fig. 6.
X
ABCG2 p.Lys453Asp 20203106:317:21
status: VERIFIED319 The concentration-dependent effects of prazosin on the binding of 5D3 to wild-type and mutant BCRP over a concentration range of 0 to 100 M were determined by using flow cytometry as described. Shown are means Ϯ S.D. of three independent experiments for the pcDNA control (f), wild-type BCRP (Œ), K452A (छ), K453D (ࡗ), H457A (F), R465A (Ⅺ), and K473A (‚).
X
ABCG2 p.Lys453Asp 20203106:319:334
status: VERIFIED329 In contrast, substitutions of Lys453 and Arg465 with Asp (K453D) or Ala (R465A) caused a nonselective global reduction in BCRP activity (Tables 1 and 2).
X
ABCG2 p.Lys453Asp 20203106:329:30
status: VERIFIEDX
ABCG2 p.Lys453Asp 20203106:329:58
status: VERIFIED339 Substitution of Lys453 with Asp would abolish the salt bridge and affect the shape of substrate binding sites and the conformation of BCRP, leading to an overall loss of transport activity.
X
ABCG2 p.Lys453Asp 20203106:339:16
status: VERIFIED363 K452A and H457A were associated with a 50 to 70% decrease in Km and a 2to 5-fold increase in Vmax/Km for ATP hydrolysis, whereas the Vmax/Km values of K453D and R465A were decreased by 40 to 70%, and the Km values of K453D and R465A did not change much (Table 3).
X
ABCG2 p.Lys453Asp 20203106:363:151
status: VERIFIEDX
ABCG2 p.Lys453Asp 20203106:363:152
status: NEW364 This suggests that ATP binding affinity and/or the efficiency of ATP hydrolysis are increased for K452A and H457A, but decreased for K453D and R465A, thus affecting BCRP activity accordingly.
X
ABCG2 p.Lys453Asp 20203106:364:133
status: VERIFIED375 Prazosin differentially increased 5D3 binding to wild-type BCRP, K452A, K453D, H457A, and R465A, but had little effect on 5D3 binding to K473A (Fig. 6).
X
ABCG2 p.Lys453Asp 20203106:375:72
status: VERIFIED